We are delighted to offer our 1-day course, which is aimed at clinical, operational and research staff working on trials who are not health economists (e.g. trial managers, project managers, chief investigators/principal investigators, clinical staff, statisticians, data managers, research assistants, etc.). We designed the course in response to the need we had identified working on trials with various trials units in UCL and elsewhere, as well as in response to requests from colleagues across our associated trials units. This course was the first of its kind, intended specifically for non health economists working in trials, who wish to better understand the health economics and health economist in their study.
We first ran this as a 1-day in-person course in July 2019, with the first online version taking place in November 2020. We are currently offering in-person editions, and this course in July 2024 will be held at the UCL Institute of Clinical Trials Methodology in London.
Sessions will be led by members of the HEART, and will include small group discussions and practical exercises, to help participants consolidate their learning and see how to apply information from the sessions to real studies. No prior knowledge of health economics is assumed. Numbers are limited to 20 participants, and all participants are expected to attend all sessions on the day.
By the end of the course, participants will be able to:
1. Explain the importance of health economics in clinical trials (aims, objectives, interpretation and limitations)
2. Facilitate and justify meaningful and timely collaboration with the health economist on development of trial documents and processes (i.e. funding application, protocol, case report forms and analysis plan)
· Identify challenges in data collection for health economic evaluations alongside trials (especially resource use and other cost data)
· Compare patient-reported outcome measures (PROMs) in terms of their strengths and weaknesses for health economic evaluations alongside trials
· Evaluate analysis approaches used in trial-based economic evaluations and the relationship of these with trial planning and data collection
· Explain the importance of clarity and consistency of the protocol’s economic evaluation section with other aspects of the protocol
3. Interpret the results of economic evaluations alongside trials.
Location: UCL Institute of Clinical Trials and Methodology, 2nd floor, rooms M02/M03, 90 High Holborn, London, WC1V 6LJ.
Date: Wednesday 17th July 2024, arrive at 9.30am for 10am start. Sessions will finish at 4pm.
Attendee fees are as follows:
Early bird prices until 23.59 on Wed 29 May 2024
· Early bird students/ICTM staff: £95
· Early bird academia/NHS/Local Authority: £140
· Early bird industry/private individual: £230
Standard rate from 00.00 on Thu 30 May 2024
· Standard rate students/ICTM staff: £135
· Standard rate academia/NHS/Local Authority: £170
· Standard rate industry/private individual: £290
If you wish to take advantage of any discounts, please use your institutional email address when booking. You will be able to pay by credit/debit card, or by providing UCL internal budget codes for an inter-departmental transfer.
If you have any questions, please contact Caroline (caroline.clarke (at) ucl.ac.uk).